DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings.

The model, 34, and the comedian, 37, who are parents to daughter Elsie, two, became engaged when he popped the question in ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD).

One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ large—is ...

San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems. Valued at $24.8 billion by market ...

People with dementia who received a shingles vaccine were significantly less likely to die from dementia than those who didn’t get the shot, according to findings of a large study, suggesting the ...

PODD holds a Zacks Rank #2. For 2026, its revenues and EPS are expected to grow 19.8% and 26.3%, respectively. The company’s ...

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.